Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus

Mol Immunol. 2011 Jul;48(12-13):1397-407. doi: 10.1016/j.molimm.2011.03.015. Epub 2011 Apr 9.

Abstract

We analyzed the contribution of TNF-α intracellular pathway in the development of apoptosis in the liver of streptozotocin-induced diabetic rats. In liver tissue, diabetes promoted a significant increase of TNF-α/TNF-R1, and led to the activation of caspase-8, of nuclear factor kappa B (NFκB), and JNK signaling pathways. The activation of NFκB led to an induction of iNOS and consequent increase in NO production. As a consequence of such changes a significant increase of caspase-3 activity and of apoptotic index were observed in the liver of diabetic animals. Importantly, the treatment in vivo of diabetic rats with etanercept (TNF-α blocking antibody) or aminoguanidine (selective iNOS inhibitor) significantly attenuated the induction of apoptosis by reduction of caspase-3 activity. Overall, we demonstrated that in the diabetes enhances TNF-α in the liver, which may be a fundamental key leading to apoptotic cell death, through activation of caspase-8, NFκB and JNK pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis*
  • Blotting, Western
  • Caspase 3 / metabolism
  • Caspase 8 / metabolism
  • Caspase Inhibitors
  • Diabetes Mellitus, Experimental
  • Diabetes Mellitus, Type 1 / metabolism*
  • Diabetes Mellitus, Type 1 / pathology
  • Electron Spin Resonance Spectroscopy
  • Etanercept
  • Guanidines / pharmacology
  • Immunoglobulin G / pharmacology
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Liver / metabolism*
  • Liver / pathology
  • Male
  • NF-kappa B / metabolism
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Tumor Necrosis Factor
  • Signal Transduction
  • Streptozocin
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Caspase Inhibitors
  • Guanidines
  • Immunoglobulin G
  • NF-kappa B
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Streptozocin
  • Nitric Oxide Synthase Type II
  • JNK Mitogen-Activated Protein Kinases
  • Caspase 3
  • Caspase 8
  • Etanercept
  • pimagedine